Neudolox (Pregabalin)

Pregabalin binds to the α2δ subunit of voltage‑gated calcium channels in the central nervous system. This reduces calcium entry into nerve terminals, decreasing the release of excitatory neurotransmitters like glutamate, norepinephrine, and substance P, which helps to dampen abnormal neuronal firing responsible for pain, seizures, and anxiety.

The appropriate dose of Neudolox is individualized by the prescribing clinician based on the specific indication, patient age, renal function, and response to therapy. Dosage titration follows established clinical guidelines, and patients should follow the prescriber’s instructions without self‑adjusting the amount.

Safety data for pregabalin in pregnancy and lactation are limited. The drug should only be used if the potential benefit justifies any potential risk to the fetus. Women who are breastfeeding should discuss alternatives with their healthcare provider, as pregabalin may be excreted in breast milk.

To request Neudolox, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and assistance with import documentation.

The primary alternative to pregabalin is gabapentin, another gabapentinoid. Both share a similar mechanism, but pregabalin generally has higher bioavailability, more predictable pharmacokinetics, and may achieve therapeutic effect at lower doses. Choice between them depends on individual patient response, tolerability, and prescriber preference.

Neudolox should be stored at room temperature, below 25 °C (77 °F). Keep the tablets in the original blister pack or container, protect them from moisture, excessive heat, and direct sunlight. Do not store in the bathroom or near a kitchen sink where humidity is high.

Neudolox is taken orally, usually with or without food, as directed by the prescriber. Tablets should be swallowed whole with a glass of water. Patients should not crush, chew, or split the tablets unless specifically instructed, to maintain consistent absorption.

Serious risks include the development of suicidal thoughts or behavior, severe allergic reactions such as angioedema, respiratory depression when combined with other CNS depressants, and rare skin conditions like Stevens‑Johnson syndrome. Patients should seek immediate medical attention if they notice rash, swelling of the face or throat, or changes in mood.

Neudolox is contraindicated in patients with known hypersensitivity to pregabalin or any of the tablet’s excipients. Caution is advised for individuals with severe renal impairment, uncontrolled psychiatric illness, or those taking multiple CNS depressants. Pregnant or nursing women should only use it when clearly needed and after consulting a healthcare professional.